Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al

Comment on study by Backman et al

BfArM acknowledges the submission of the manuscript by Backman et al. (2005) concerning the occurrence of breast cancer associated with Mirena use. The manuscript was scheduled for publication in October 2005 and meanwhile has been published (Backman T. et al. Use of the Levonorgestrel-releasing intrauterine system and breast cancer. Obstet and Gynecol 2005;106:813-7). Unfortunately, the study ...

Comment on Article by Celeux Et Al

The authors point to several problems occurring if DIC = 2D(θ) − D(θ) is applied to missing data models: (i) the focus of the model depends on whether the missing data z are considered as observations or as parameters or integrated out; (ii) the parameter θ may be non-identifiable; (iii) θ can be a poor estimator of θ. They then investigate modifications of DIC mainly based on estimates other t...

Tumor necrosis factor and anti-tumor necrosis factor therapies.

Tumor necrosis factor (TNF) plays a crucial role in the pathogenesis of immune-mediated inflammatory diseases (IMID). As a result, the inhibition of TNF is an important therapeutic avenue in the treatment of these pathophysiologically diverse disease states. This section discusses TNF, its receptors, and its role in immunoregulation and inflammation, as well as the currently available anti-TNF-...

Comment on Yuan Et Al

It has come to our attention that the work of Yuan et al. [1] is being represented as definitive regarding the existence of a particular nonstrange, isoscalar, spin three dibaryon, d * , which we [2] , among others [3, 4, 5, 6, 8] , have proposed exists. We therefore wish to comment on this paper and its relation to ours and those of others. In our work [2] , the d * dibaryon is constructed in ...

Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senécal et al.